Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Surgery in Early Metastatic Seminoma (SEMS): Phase II Trial of Retroperitoneal Lymph Node Dissection as First-Line Treatment for Testicular Seminoma With Isolated Retroperitoneal Disease (1-3cm)

NCT02537548 is registered in ClinicalTrials.gov with University of Southern California as lead sponsor.

NCT NCT02537548
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT02537548 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Surgery in Early Metastatic Seminoma (SEMS): Phase II Trial of Retroperitoneal Lymph Node Dissection as First-Line Treatment for Testicular Seminoma With Isolated Retroperitoneal Disease (1-3cm)
Lead sponsor
University of Southern California
Phase
Not applicable
Overall status
Active, not recruiting
Start date
August 28, 2015
Completion date
December 31, 2027
Enrollment
55 (actual)
Sites
14

Conditions

As the registry lists them; a condition with its own page is linked.

lymphadenopathy, stage i testicular seminoma, stage ii testicular seminoma